Docebo (DCBO) Competitors

$36.97
+0.17 (+0.46%)
(As of 05/16/2024 ET)

DCBO vs. EVBG, VTEX, SPT, SOUN, ZUO, BASE, ENFN, PDFS, OPRA, and FSLY

Should you be buying Docebo stock or one of its competitors? The main competitors of Docebo include Everbridge (EVBG), VTEX (VTEX), Sprout Social (SPT), SoundHound AI (SOUN), Zuora (ZUO), Couchbase (BASE), Enfusion (ENFN), PDF Solutions (PDFS), Opera (OPRA), and Fastly (FSLY). These companies are all part of the "prepackaged software" industry.

Docebo vs.

Docebo (NASDAQ:DCBO) and Everbridge (NASDAQ:EVBG) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Docebo has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, Everbridge has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.

Docebo has a net margin of 3.55% compared to Everbridge's net margin of -11.67%. Docebo's return on equity of 19.31% beat Everbridge's return on equity.

Company Net Margins Return on Equity Return on Assets
Docebo3.55% 19.31% 8.62%
Everbridge -11.67%5.26%1.52%

Docebo has higher earnings, but lower revenue than Everbridge. Everbridge is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Docebo$190.78M5.89$2.84M$0.22168.05
Everbridge$448.79M3.22-$47.31M-$1.56-22.28

In the previous week, Docebo had 20 more articles in the media than Everbridge. MarketBeat recorded 31 mentions for Docebo and 11 mentions for Everbridge. Everbridge's average media sentiment score of -0.02 beat Docebo's score of -0.04 indicating that Everbridge is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Docebo
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
11 Negative mention(s)
0 Very Negative mention(s)
Neutral
Everbridge
1 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Everbridge received 375 more outperform votes than Docebo when rated by MarketBeat users. However, 66.67% of users gave Docebo an outperform vote while only 66.51% of users gave Everbridge an outperform vote.

CompanyUnderperformOutperform
DoceboOutperform Votes
52
66.67%
Underperform Votes
26
33.33%
EverbridgeOutperform Votes
427
66.51%
Underperform Votes
215
33.49%

Docebo presently has a consensus target price of $55.00, indicating a potential upside of 48.77%. Everbridge has a consensus target price of $29.75, indicating a potential downside of 14.41%. Given Docebo's stronger consensus rating and higher possible upside, equities research analysts clearly believe Docebo is more favorable than Everbridge.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Docebo
0 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.91
Everbridge
1 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.90

53.2% of Docebo shares are owned by institutional investors. Comparatively, 90.0% of Everbridge shares are owned by institutional investors. 0.4% of Everbridge shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Docebo beats Everbridge on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DCBO vs. The Competition

MetricDoceboPrepackaged software IndustryComputer SectorNASDAQ Exchange
Market Cap$1.12B$22.17B$20.76B$7.96B
Dividend YieldN/A2.05%2.75%3.93%
P/E Ratio168.0578.03260.8318.77
Price / Sales5.8974.55527.0879.11
Price / Cash60.2665.1728.5331.19
Price / Book18.869.376.844.47
Net Income$2.84M$366.17M$632.85M$217.14M
7 Day Performance-20.41%1.23%1.52%1.88%
1 Month Performance-16.28%4.99%4.63%5.32%
1 Year Performance14.85%20.35%33.53%11.55%

Docebo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVBG
Everbridge
2.8152 of 5 stars
$34.77
-0.1%
$29.00
-16.6%
+45.0%$1.44B$448.79M-24.311,593Analyst Forecast
VTEX
VTEX
1.6743 of 5 stars
$8.13
+0.6%
$8.44
+3.8%
+85.3%$1.50B$201.52M-116.131,277Analyst Upgrade
Gap Up
SPT
Sprout Social
2.7919 of 5 stars
$27.09
-4.2%
$57.07
+110.7%
-31.5%$1.52B$333.64M-21.671,383Analyst Forecast
High Trading Volume
SOUN
SoundHound AI
3.184 of 5 stars
$4.94
-5.2%
$6.88
+39.3%
+111.2%$1.53B$45.87M-12.67260Analyst Revision
ZUO
Zuora
1.5377 of 5 stars
$10.52
+1.3%
$12.00
+14.1%
+28.4%$1.54B$431.66M-21.921,618Upcoming Earnings
Analyst Forecast
BASE
Couchbase
3.3439 of 5 stars
$26.03
0.0%
$32.40
+24.5%
+58.5%$1.31B$180.04M-15.31796
ENFN
Enfusion
0.9364 of 5 stars
$9.73
-0.5%
$9.33
-4.1%
+27.8%$1.25B$174.54M121.641,102Positive News
PDFS
PDF Solutions
3.3922 of 5 stars
$32.34
+0.1%
$46.00
+42.2%
-8.9%$1.24B$165.84M462.00493
OPRA
Opera
4.3292 of 5 stars
$13.76
+0.3%
$21.17
+53.8%
-0.1%$1.22B$396.83M7.32592
FSLY
Fastly
4.2816 of 5 stars
$8.52
-3.0%
$15.17
+78.1%
-30.9%$1.16B$505.99M-8.521,207Short Interest ↑

Related Companies and Tools

This page (NASDAQ:DCBO) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners